Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION - NEUROONE MEDICAL TECHNOLOGIES Corp | f10k2020a2ex31-2_neuro.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - NEUROONE MEDICAL TECHNOLOGIES Corp | f10k2020a2ex23-1_neuro.htm |
| 10-K/A - AMENDMENT NO. 2 TO FORM 10-K - NEUROONE MEDICAL TECHNOLOGIES Corp | f10k2020a2_neuroonemedical.htm |
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO EXCHANGE ACT RULE 13a-14(a) OR 15d-14(a), AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES OXLEY ACT OF 2002
I, David Rosa, certify that:
| 1 | I have reviewed Amendment No. 1 to the annual report on Form 10-K for the year ended September 30, 2020 (the “report”) of NeuroOne Medical Technologies Corporation; and |
| 2 | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
| Date: February 12, 2021 | ||
| By: | /s/ David Rosa | |
| Name: | David Rosa | |
| Title: | Chief Executive Officer | |
| (Principal Executive Officer) |